Product Information
TRIHEXYPHENIDYL 2 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0884 per EA under NDC 00591533501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591533501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRIHEXYPHENIDYL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA084363FDA Approved
Before 1982
TE Code
AA
On Market Since
11/1/1987
Price Statistics
The NADAC for TRIHEXYPHENIDYL 2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0884 per EA |
|---|---|
| All-time high | $0.1816 (Mar 12, 2014) |
| All-time low | $0.0449 (Jun 17, 2015) |
| 52-week high | $0.0907 |
| 52-week low | $0.0756 |
| Median price | $0.0568 |
| Average price | $0.0614 |
| Largest weekly change | +254.6% (Dec 18, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trihexyphenidyl Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIHEXYPHENIDYL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIHEXYPHENIDYL 2 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0884 per EA (NDC 00591533501), effective Sep 30, 2026.
How has the price of TRIHEXYPHENIDYL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIHEXYPHENIDYL 2 MG TABLET has risen 79.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIHEXYPHENIDYL 2 MG TABLET?
Since Nov 28, 2013, the NADAC for TRIHEXYPHENIDYL 2 MG TABLET has ranged from a low of $0.0449 (Jun 17, 2015) to a high of $0.1816 (Mar 12, 2014), with a median of $0.0568 per EA.
Are there cheaper alternatives to TRIHEXYPHENIDYL 2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIHEXYPHENIDYL 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIHEXYPHENIDYL 2 MG TABLET?
TRIHEXYPHENIDYL 2 MG TABLET (NDC 00591533501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.